528 related articles for article (PubMed ID: 18630936)
1. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
[TBL] [Abstract][Full Text] [Related]
2. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
3. Molecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material.
Mellaerts R; Roeffaers MB; Houthoofd K; Van Speybroeck M; De Cremer G; Jammaer JA; Van den Mooter G; Augustijns P; Hofkens J; Martens JA
Phys Chem Chem Phys; 2011 Feb; 13(7):2706-13. PubMed ID: 21152589
[TBL] [Abstract][Full Text] [Related]
4. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials.
Mellaerts R; Aerts CA; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
Chem Commun (Camb); 2007 Apr; (13):1375-7. PubMed ID: 17377687
[TBL] [Abstract][Full Text] [Related]
5. Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole.
Van Speybroeck M; Mols R; Mellaerts R; Thi TD; Martens JA; Van Humbeeck J; Annaert P; Van den Mooter G; Augustijns P
Eur J Pharm Biopharm; 2010 Aug; 75(3):354-65. PubMed ID: 20420905
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen.
Vialpando M; Backhuijs F; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2012 May; 81(1):190-8. PubMed ID: 22306694
[TBL] [Abstract][Full Text] [Related]
7. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.
Mellaerts R; Mols R; Jammaer JA; Aerts CA; Annaert P; Van Humbeeck J; Van den Mooter G; Augustijns P; Martens JA
Eur J Pharm Biopharm; 2008 May; 69(1):223-30. PubMed ID: 18164930
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica material TUD-1 as a drug delivery system.
Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
[TBL] [Abstract][Full Text] [Related]
9. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM
Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
[TBL] [Abstract][Full Text] [Related]
11. Potential of amorphous microporous silica for ibuprofen controlled release.
Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
[TBL] [Abstract][Full Text] [Related]
12. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.
Shen SC; Ng WK; Chia L; Hu J; Tan RB
Int J Pharm; 2011 May; 410(1-2):188-95. PubMed ID: 21419202
[TBL] [Abstract][Full Text] [Related]
13. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug.
Hu Y; Wang J; Zhi Z; Jiang T; Wang S
J Colloid Interface Sci; 2011 Nov; 363(1):410-7. PubMed ID: 21820127
[TBL] [Abstract][Full Text] [Related]
14. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
[TBL] [Abstract][Full Text] [Related]
15. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
Song SW; Hidajat K; Kawi S
Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037
[TBL] [Abstract][Full Text] [Related]
16. Control of drug release through the in situ assembly of stimuli-responsive ordered mesoporous silica with magnetic particles.
Zhu S; Zhou Z; Zhang D
Chemphyschem; 2007 Dec; 8(17):2478-83. PubMed ID: 17952885
[TBL] [Abstract][Full Text] [Related]
17. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
18. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
[TBL] [Abstract][Full Text] [Related]
19. Comparison of fenofibrate-mesoporous silica drug-loading processes for enhanced drug delivery.
Ahern RJ; Hanrahan JP; Tobin JM; Ryan KB; Crean AM
Eur J Pharm Sci; 2013 Nov; 50(3-4):400-9. PubMed ID: 23981335
[TBL] [Abstract][Full Text] [Related]
20. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]